logo

For the Inventor, By the Inventor

Hofheim am Taunus, Germany

Volker Teetz

USPTO Granted Patents = 48

Average Co-Inventor Count = 4.0

ph-index = 15

Forward Citations = 466(Granted Patents)


Location History:

  • Hofheim, DE (1981 - 1985)
  • Holheim am Taunus, DE (1993)
  • Hofheim am Taunus, DE (1978 - 1998)

Company Filing History:

goldMedal44 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal3 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
bronzeMedal1 out of 1 
 
Hoechst Aktiengesellschafat
 patent

Years Active: 1978-1998

Loading Chart...
Areas of Expertise:
Cardiac Insufficiency
Angiotensin-Converting Enzyme Inhibitors
Calcium Combination Therapy
Bicyclic Aminoacids
Peptide Derivatives
Optically Active Bicyclic Compounds
Hypertensive Agents
Chromogenic Compounds
Insulin Derivatives
Cyclic Peptides
Pharmaceutical Compositions
Racemates Resolution
48 patents (USPTO):Explore Patents
1. 5747504 - Method of treating cardiac insufficiency using angiotensin-converting (1998-05-05),
2. 5744496 - Method of treating cardiac insufficiency using angiotensin-converting (1998-04-28),
3. 5721244 - Combination of angiotensin-converting enzyme inhibitors with calcium (1998-02-24),
4. 5684016 - Method of treating cardiac insufficiency (1997-11-04),
5. 5500434 - Combination of angiotensin-converting enzyme inhibitors with calcium (1996-03-19),
6. 5403856 - Method of treating cardiac insufficiency using angiotensin-converting (1995-04-04),
7. 5401766 - Aminoacid derivatives, a process for their preparation, agents (1995-03-28),
8. 5366994 - Use of a combination of angiotensin-converting enzyme inhibitor and (1994-11-22),
9. 5256687 - Pharmaceutical composition for the treatment of high blood pressure (1993-10-26),
10. 5236933 - Use of a combination of angiotensin-converting enzyme inhibitor and (1993-08-17),
11. 5231083 - Method for the treatment of cardiac and of vascular hypertrophy and (1993-07-27),
12. 5175306 - Process for the resolution of racemates of optically active bicyclic (1992-12-29),
13. 5162362 - Octahydroindole-2-carboxylic acids (1992-11-10),
14. 5158959 - Decahydroisoquinoline carboxylic acids (1992-10-27),
15. 5112806 - Antibiotic, mersacidin, a process for the preparation thereof and the (1992-05-12),

Title: The Inventive Journey of Volker Teetz: Pioneering Treatments for Cardiac Insufficiency

Introduction:

Volker Teetz, a distinguished inventor hailing from Hofheim am Taunus, DE, has established himself as a trailblazer in the field of medicine with a remarkable 48 patents to his name. His groundbreaking work revolves around developing innovative methods to treat cardiac insufficiency, significantly impacting the healthcare industry.

Latest Patents:

Teetz's latest patents showcase his dedication to advancing medical treatments. One notable invention is the method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors. This method involves utilizing compounds that have shown promising results in combatting the disease, offering new hope for patients facing cardiac challenges.

Career Highlights:

Throughout his career, Volker Teetz has made significant contributions while working at esteemed companies such as Hoechst Aktiengesellschaft and Behringwerke Aktiengesellschaft. His expertise and innovative spirit have led to the development of cutting-edge solutions that have the potential to transform the healthcare landscape.

Collaborations:

Teetz's collaborations with renowned coworkers like Hansjorg Urbach and Rolf Geiger have been instrumental in shaping his inventive journey. Together, they have synergized their skills and knowledge to push the boundaries of medical research, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, Volker Teetz stands as a beacon of innovation in the realm of healthcare, continuously striving to enhance the quality of life for individuals suffering from cardiac insufficiency. His remarkable achievements and relentless pursuit of novel solutions underscore his commitment to driving positive change through his inventive pursuits.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…